Correcting for misclassification and selection effects in estimating net survival in clinical trials
Author:
Funder
A*MIDEX
Agence Nationale de la Recherche
Publisher
Springer Science and Business Media LLC
Subject
Health Informatics,Epidemiology
Link
http://link.springer.com/content/pdf/10.1186/s12874-019-0747-3.pdf
Reference38 articles.
1. Narod S. Can advanced-stage ovarian cancer be cured? Nat Rev Clin Oncol. 2016;13:255–61.
2. Crowder MJ. Multivariate Survival Analysis and Competing Risks. 0 edition. Chapman and Hall/CRC; 2012. https://doi.org/10.1201/b11893 .
3. Giorgi R. Challenges in the estimation of net SURvival: the CENSUR working survival group. Rev Epidemiol Sante Publique. 2016;64:367–71.
4. Dignam JJ, Huang L, Ries L, Reichman M, Mariotto A, Feuer E. Estimating breast Cancer-specific and other-cause mortality in clinical trial and population-based Cancer registry cohorts. Cancer. 2009;115:5272–83.
5. Schaffar R, Rachet B, Belot A, Woods LM. Estimation of net survival for cancer patients: relative survival setting more robust to some assumption violations than cause-specific setting, a sensitivity analysis on empirical data. Eur J Cancer. 2017;72:78–83.
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Systematic review: Mortality associated with raised faecal immunochemical test and positive faecal occult blood results;Alimentary Pharmacology & Therapeutics;2024-08-20
2. Fair comparisons of cause-specific and relative survival by accounting for the systematic removal of patients from risk-sets;Cancer Epidemiology;2023-10
3. A new cure model that corrects for increased risk of non-cancer death: analysis of reliability and robustness, and application to real-life data;BMC Medical Research Methodology;2023-03-25
4. Correcting for heterogeneity and non‐comparability bias in multicenter clinical trials with a rescaled random‐effect excess hazard model;Biometrical Journal;2023-03-08
5. Is the Social Gradient in Net Survival Observed in France the Result of Inequalities in Cancer-Specific Mortality or Inequalities in General Mortality?;Cancers;2023-01-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3